A rare case of clomiphene-induced leukocytoclastic vasculitis

J Basic Clin Physiol Pharmacol. 2019 Jul 18;30(4). doi: 10.1515/jbcpp-2018-0183.

Abstract

Clomiphene citrate is a first-line drug for the induction of ovulation in infertility cases. Leukocytoclastic vasculitis (LCV) is an extremely rare serious adverse drug reaction to clomiphene. We report here the case of a 30-year-old Indian female patient who presented with generalized petechiae and palpable purpura without fever and sparing the mucosa, temporally related to clomiphene intake and consistent with LCV histologically. Clomiphene was stopped and the patient was treated symptomatically with prednisolone 40 mg/day, oral levocetirizine 5 mg twice daily, and emollients and calamine lotion topically. The patient improved over 3-4 weeks. The prednisolone dose was tapered weekly and withdrawn gradually. To date, drug-induced LCV has not been previously reported with clomiphene. Although rare, clomiphene could be considered a potential cause of drug-induced cutaneous LCV in the differential diagnosis of erythematosus rash with non-blanching petechiae and purpura.

Keywords: adverse drug reaction; clomiphene; leukocytoclastic vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Clomiphene / adverse effects*
  • Clomiphene / therapeutic use
  • Female
  • Humans
  • Ovulation / drug effects
  • Vasculitis, Leukocytoclastic, Cutaneous / chemically induced*

Substances

  • Clomiphene

Supplementary concepts

  • Erythema elevatum diutinum